A-803467

A Potent and Selective Blocker of the TTX-Resistant NaV1.8 Channel
    Cat #: A-105
  • Lyophilized Powder
  • Bioassay Tested
  • Source Synthetic
    MW: 357.8
    Purity: >99% (HPLC)
    Effective concentration 10 nM - 10 μM.
    Structure
    • A-803467
    Chemical name 5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)-2-furancarboxamide.
    Molecular formula C19H16ClNO4.
    CAS No.: 944261-79-4.
    Activity A-803467 is a potent and selective blocker of the TTX-resistant NaV1.8 channel. A-803467 is a state dependent inhibitor with IC50 of 8 nM at depolarized membrane potential (-40 mV) and 80 nM at -100 mV. As an efficient inhibitor of TTX-resistant currents in DRG neurons, A-803467 was also effective as an analgesic in several rodent models of different pathological pain states1,2. A-803467 was used as a pharmacological tool to demonstrate the expression of NaV1.8 in the heart conduction system and its contribution to QRS interval in the mouse heart3.
    References-Activity
    1. Jarvis, M.F. et al. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 8520.
    2. McGaraughty, S. et al. (2008) J.Pharmacol. Exp. Ther. 324, 1204.
    3. Sotoodehnia, N. et al. (2010) Nat. Gen. 42, 1068.
    Shipping and storage Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
    Solubility DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
    Storage of solutions Up to four weeks at 4°C or three months at -20°C.
    Our bioassay
    • A-803467
      Alomone Labs A-803467 inhibits NaV1.8 channels stably transfected in ND7/23 cells.
      Currents were elicited by 50 ms voltage ramp from the holding potential of -100 mV to +60 mV, applied every 10 sec, using whole-cell voltage clamp technique. A. Time course of NaV1.8 current amplitude changes as a result of A-803467 (#A-105) application at increasing concentrations, as indicated by the horizontal bars. B. Superimposed traces of NaV1.8 currents under control conditions and after 100 sec perfusion with 10-8-10-6 M A-803467, as indicated.
    References - Scientific background
    1. Renganathan, M. et al. (2001) J. Neurophysiol. 86, 629.
    2. Lai, J. et al. (2002) Pain 95, 143.
    3. Zimmermann, K. et al. (2007) Nature 447, 855.
    4. Jarvis, M.F. et al. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 8520.
    5. McGaraughty, S. et al. (2008) J.Pharmacol. Exp. Ther. 324, 1204.
    6. Sotoodehnia, N. et al. (2010) Nat. Gen. 42, 1068.
    Scientific background

    The TTX-resistant NaV1.8 channel is expressed almost exclusively in the PNS and has been shown to mediate most of the well documented TTX-resistant currents of DRG neurons' action potentials1. Hyperexcitability, manifested by increased action potential firing and coded information transfer to the CNS of nociceptive DRG neurons, probably lie on the basis of several pathological pain states. Both genetic and pharmacological evidence suggest that NaV1.8 channel might serve as a target in pain control2-4.

    A-803467 is a potent and selective blocker of the TTX-resistant NaV1.8 channel4. A-803467 is a state dependent inhibitor with IC50 8 nM at depolarized membrane potential (-40 mV) and 80 nM at -100 mV. As an efficient inhibitor of TTX-resistant currents in DRG neurons, A-803467 was also effective as an analgesic in several rodent models of different pathological pain states4,5. A-803467 was used as a pharmacological tool to demonstrate the expression of NaV1.8 in the heart conduction system and its contribution to QRS interval in the mouse heart6.

    Target NaV1.8 Na+ channels
    Last update: 24/01/2020

    A-803467 (#A-105) is a highly pure, synthetic, and biologically active compound.

    For research purposes only, not for human use
    Shipping and Ordering information